GE HealthCare Technologies Inc. $GEHC Stock Holdings Lifted by Wealthcare Advisory Partners LLC

Wealthcare Advisory Partners LLC raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,682 shares of the company’s stock after buying an additional 733 shares during the period. Wealthcare Advisory Partners LLC’s holdings in GE HealthCare Technologies were worth $347,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. Glenview Trust co increased its stake in GE HealthCare Technologies by 4.4% in the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after acquiring an additional 139 shares during the period. Silver Oak Securities Incorporated increased its stake in GE HealthCare Technologies by 4.6% in the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after acquiring an additional 140 shares during the period. Chicago Capital LLC increased its stake in GE HealthCare Technologies by 2.2% in the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after acquiring an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH increased its stake in GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after acquiring an additional 143 shares during the period. Finally, Knuff & Co LLC increased its stake in GE HealthCare Technologies by 1.5% in the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock valued at $829,000 after acquiring an additional 150 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC opened at $74.22 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The company’s 50 day simple moving average is $74.28 and its 200-day simple moving average is $72.42. The stock has a market capitalization of $33.89 billion, a P/E ratio of 15.21, a price-to-earnings-growth ratio of 2.87 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the firm earned $1.00 earnings per share. GE HealthCare Technologies’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is 2.87%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on GEHC shares. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $93.00 to $83.00 in a research note on Tuesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $85.78.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.